» Articles » PMID: 32866468

A Critical Review: Psychophysical Assessments of Diabetic Retinopathy

Overview
Journal Surv Ophthalmol
Specialty Ophthalmology
Date 2020 Sep 1
PMID 32866468
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic retinal disease remains a leading cause of vision loss despite currently available screening methods, ocular treatments, and efforts to control metabolic dysfunction. It is now understood that diabetes damages the entire retina and the cellular components of the neurovascular unit. Multiple studies have demonstrated impairment of various aspects of retinal function across the spectrum of retinopathy severity. Here we review these tests, the principles underlying their use, clinical data from multiple publications, the strengths and limitations of the studies, and prospects for their application to understand the pathophysiology of diabetic retinal disease and monitor its response to therapy. We focus on visual acuity, contrast sensitivity, color vision, visual field, and dark adaptation and their use to understand the pathophysiology of diabetic retinopathy and as potential endpoints for clinical trials.

Citing Articles

The relationship between ON-OFF function and OCT structural and angiographic parameters in early diabetic retinal disease.

Tang V, Symons R, Fourlanos S, Guest D, McKendrick A Ophthalmic Physiol Opt. 2024; 45(1):77-88.

PMID: 39400905 PMC: 11629852. DOI: 10.1111/opo.13394.


Clinical Evidence of a Photoreceptor Origin in Diabetic Retinal Disease.

Rajagopal R, Kern T Ophthalmol Sci. 2024; 5(1):100591.

PMID: 39328824 PMC: 11426126. DOI: 10.1016/j.xops.2024.100591.


Visual Function Measurements in Eyes With Diabetic Retinopathy: An Expert Opinion on Available Measures.

Glassman A, Elmasry M, Baskin D, Brigell M, Chong V, Davis Q Ophthalmol Sci. 2024; 4(5):100519.

PMID: 38881606 PMC: 11179417. DOI: 10.1016/j.xops.2024.100519.


Aflibercept 5+PRN with retinal laser photocoagulation is more effective than retinal laser photocoagulation alone and aflibercept 3+PRN with retinal laser photocoagulation in patients with high-risk proliferative diabetic retinopathy and diabetic....

Li S, Tao Y, Yang M, Zhao H, Si M, Cui W Front Endocrinol (Lausanne). 2024; 15:1286736.

PMID: 38455651 PMC: 10919144. DOI: 10.3389/fendo.2024.1286736.


Achromatic and chromatic contrast discrimination in patients with type 2 diabetes.

Tsai L, Chen C, Hou C, Liao K Sci Rep. 2023; 13(1):7420.

PMID: 37156848 PMC: 10167204. DOI: 10.1038/s41598-023-34407-1.


References
1.
Nittala M, Gella L, Raman R, Sharma T . Measuring retinal sensitivity with the microperimeter in patients with diabetes. Retina. 2012; 32(7):1302-9. DOI: 10.1097/IAE.0b013e3182365a24. View

2.
Bodis-Wollner I . Visual acuity and contrast sensitivity in patients with cerebral lesions. Science. 1972; 178(4062):769-71. DOI: 10.1126/science.178.4062.769. View

3.
COGAN D, Toussaint D, Kuwabara T . Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol. 1961; 66:366-78. DOI: 10.1001/archopht.1961.00960010368014. View

4.
Al Shafaee M, Shenoy R, Bialasiewicz A, Ganguly S, Bhargava K . Macular function in prediabetic and diabetic Omani adults: a microperimetric evaluation. Eur J Ophthalmol. 2011; 21(6):771-6. DOI: 10.5301/EJO.2011.6328. View

5.
ENGERMAN R, BLOODWORTH Jr J . EXPERIMENTAL DIABETIC RETINOPATHY IN DOGS. Arch Ophthalmol. 1965; 73:205-10. DOI: 10.1001/archopht.1965.00970030207013. View